2021 Jun 6;3(8):601-610
No Phase I, II, or III trial has been completed and published in a peer-reviewed journal with systematic adverse-event reporting
Researchers position BPC-157 as a candidate for musculoskeletal repair given its apparent ability to accelerate healing timelines observed in animal studies
Its well-characterized mechanisms of action, favorable safety profile, and consistent biological effects make it an invaluable compound for researchers exploring wound healing, skin biology, hair follicle cycling, inflammatory resolution, and age-related tissue changes
Individual responses can vary, and these effects have not been established in all individuals or across all clinical settings
Treating both the symptom and the source is how you get results that last, not just a temporary cosmetic fix